title: What Do We Know Now About the Impact of the Laws Related to Marijuana?
abstract: OBJECTIVE
  This study presents information on the status and impact of medical and legalized marijuana, and the latest data on attitudes and prevalence of use since implementation of these laws. Recent reports from epidemiologists in Denver and Seattle are summarized to give the readers a sense of the changes as these laws have taken effect in their communities.
  
  
  METHODS
  The status of these laws is reviewed and the results of surveys taken before and after the laws were enacted are presented, along with data on changing potency and driving under the influence of marijuana.
  
  
  CONCLUSIONS
  Prevalence of use by youths has not increased, but their negative attitudes towards the risk of using marijuana have decreased, and use by adults has increased. Potency continues to increase, as has the proportion of drivers testing positive for use of the drug. Data from Denver show increases in hospital admissions, emergency department visits, and calls to poison centers, with decreasing arrests and admissions to substance abuse treatment programs. Data from the Seattle area show similar decreases in treatment admissions and police involvement, but also increased prevalence of more frequent use.
  
  
  CONCLUSIONS
  Current data suggest that increases in marijuana use preceded legalization in 2012. Treatment admissions were declining before these laws, but some indicators of morbidity seem to be increasing subsequent to legalization, with modest increases in poison center calls in both states and increases in acute medical visits in Denver. Data are needed to understand the relationship between the patterns and amounts of use in terms of consequences, and data on the health conditions of those receiving medical marijuana and the impact of higher potency.
authors.affiliation: Center for Social Work Research (JCM); Denver Office of Drug Strategy, 1200 Federal Boulevard, Denver, Colorado (BM).
authors.forename: Jane Carlisle
authors.initials: JC
authors.lastname: Maxwell
authors.forename: Bruce
authors.initials: B
authors.lastname: Mendelson
mesh_terms: D002188:Cannabis; D006801:Humans; D007880:Legislation, Drug; D064086:Medical Marijuana
chemical_list: D064086:Medical Marijuana
references.citation: Drug Alcohol Depend. 2012 Jun 1;123(1-3):105-9
references.pmid: 22101027
references.citation: Int J Drug Policy. 2014 Mar;25(2):308-19
references.pmid: 24502887
references.citation: N Engl J Med. 2014 Jun 5;370(23):2219-27
references.pmid: 24897085
references.citation: Drug Alcohol Depend. 2014 Oct 1;143:244-50
references.pmid: 25156224
references.citation: Drug Alcohol Rev. 2015 Mar;34(2):141-6
references.pmid: 25255903
references.citation: Int J Drug Policy. 2015 Apr;26(4):336-44
references.pmid: 25662893
references.citation: Drug Alcohol Depend. 2015 May 1;150:135-40
references.pmid: 25765482
references.citation: JAMA. 2015 Jun 23-30;313(24):2431-2
references.pmid: 26103026
references.citation: JAMA. 2015 Jun 23-30;313(24):2456-73
references.pmid: 26103030
references.citation: JAMA. 2015 Jun 23-30;313(24):2474-83
references.pmid: 26103031
references.citation: JAMA. 2015 Jun 23-30;313(24):2491-3
references.pmid: 26103034
references.citation: Drug Alcohol Depend. 2015 Sep 1;154:111-6
references.pmid: 26154479
references.citation: MMWR Morb Mortal Wkly Rep. 2015 Jul 24;64(28):771-2
references.pmid: 26203632
references.citation: Lancet Psychiatry. 2015 Jul;2(7):601-8
references.pmid: 26303557
references.citation: Am J Prev Med. 2016 Mar;50(3):373-379
references.pmid: 26385161
references.citation: Ann Emerg Med. 2015 Dec;66(6):669
references.pmid: 26918254